Andalusia has advanced breast cancer prevention with a 426% rise in investment, reaching €157.4 million (2019–2023). In 2024, 789,065 women were invited to screening, with 71.55%...
Roche's CE Mark-approved cobas Mass Spec offers automated, standardized mass spectrometry for over 60 tests, improving care for breast cancer and hormonal therapy patients. It aids...